Filing Details

Accession Number:
0000950170-25-011319
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-30 21:06:51
Reporting Period:
2025-01-28
Accepted Time:
2025-01-30 21:06:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1812364 Relay Therapeutics Inc. RLAY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1709772 A Donald Bergstrom C/O Relay Therapeutics, Inc.
399 Binney Street, 2Nd Floor
Cambridge MA 02142
President, R&D No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-01-28 3,220 $4.63 516,868 No 4 S Direct
Common Stock Acquisiton 2025-01-28 176,400 $0.00 693,268 No 4 A Direct
Common Stock Disposition 2025-01-29 46,407 $4.55 646,861 No 4 S Direct
Common Stock Disposition 2025-01-30 30,823 $4.42 616,038 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 9,071 shares of restricted stock units ("RSUs") on January 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
  2. Includes 438,719 shares underlying RSUs.
  3. Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock uponvesting.
  4. Includes 615,119 shares underlying RSUs.
  5. Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 150,000 shares of RSUs on January 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
  6. Includes 465,119 shares underlying RSUs.
  7. Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 88,200 shares of RSUs on January 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
  8. Includes 376,919 shares underlying RSUs.